Cai and colleagues reported that Bcl11b regulates the mammary epithelial stem cell quiescence, binds to the promoters of Wnt target genes and inhibits Wnt signaling in breast cancer (Bai et al, 2022; Cai et al, 2017). Here, BCL11B is linked to breast carcinoma.